Loading...
Mitsubishi Chemical Group Corporation
MTLHY•PNK
Basic Materials
Chemicals
$27.37
$0.00(0.00%)
Mitsubishi Chemical Group Corporation (MTLHY) Financial Performance & Income Statement Overview
Review Mitsubishi Chemical Group Corporation’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
0.46%
↑ 0.46%
Operating Income Growth
44.34%
↑ 44.34%
Net Income Growth
-62.36%
↓ 62.36%
Operating Cash Flow Growth
18.85%
↑ 18.85%
Operating Margin
5.24%
↑ 5.24%
Gross Margin
29.03%
↑ 29.03%
Net Profit Margin
1.02%
↑ 1.02%
ROE
2.52%
↑ 2.52%
ROIC
5.25%
↑ 5.25%
Mitsubishi Chemical Group Corporation (MTLHY) Income Statement & Financial Overview
Review Mitsubishi Chemical Group Corporation's (MTLHY) income statement with detailed quarterly and annual figures.
Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
---|---|---|---|---|
Revenue | $1075.86B | $1089.48B | $1112.71B | $1129.35B |
Cost of Revenue | $753.07B | $775.37B | $789.83B | $809.55B |
Gross Profit | $322.79B | $314.11B | $322.88B | $319.81B |
Gross Profit Ratio | $0.30 | $0.29 | $0.29 | $0.28 |
R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
SG&A Expenses | $256.002B | $242.04B | $233.62B | $238.35B |
Operating Expenses | $256.002B | $261.29B | $233.62B | $234.81B |
Total Costs & Expenses | $1009.07B | $1036.66B | $1023.45B | $1044.36B |
Interest Income | $0.00 | $4.66B | $0.00 | $7.93B |
Interest Expense | $17.10B | $2.10B | $19.89B | $15.91B |
Depreciation & Amortization | $68.40B | $68.34B | $67.98B | $71.21B |
EBITDA | $74.66B | $117.13B | $118.51B | $154.26B |
EBITDA Ratio | $0.07 | $0.11 | $0.11 | $0.14 |
Operating Income | $66.79B | $52.82B | $89.26B | $85.00B |
Operating Income Ratio | $0.06 | $0.05 | $0.08 | $0.08 |
Other Income/Expenses (Net) | -$78.54B | -$1.46B | -$61.31B | -$7.98B |
Income Before Tax | -$11.75B | $51.36B | $27.95B | $77.02B |
Income Before Tax Ratio | -$0.01 | $0.05 | $0.03 | $0.07 |
Income Tax Expense | -$9.68B | $19.79B | $14.22B | $20.72B |
Net Income | -$14.35B | $18.45B | $1.27B | $39.65B |
Net Income Ratio | -$0.01 | $0.02 | $0.001 | $0.04 |
EPS | -$10.08 | $12.96 | $0.89 | $27.87 |
Diluted EPS | -$10.08 | $12.96 | $0.89 | $27.85 |
Weighted Avg Shares Outstanding | $1.42B | $1.42B | $1.43B | $1.42B |
Weighted Avg Shares Outstanding (Diluted) | $1.42B | $1.42B | $1.43B | $1.42B |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan